Melisa Sigley and Monisha Prakash, Medical Science Liaisons from AstraZeneca, join us to talk about a long-acting monoclonal antibody for pre-exposure prophylaxis of COVID-19 for specific individuals, known as EVUSHELD™ (tixagevimab co-packaged with cilgavimab). Please click on the link below to refer to the EVUSHELD™ Fact Sheet for Healthcare Providers for up-to-date and further product information. For any medical information requests and access to other AstraZeneca resources, please contact Melisa Sigley or visit AZmedical.com.
https://www.azpicentral.com/pi.html?product=evusheld_hcp_fact
